# Study of an Innovative Therapy Using CAR-T Cells Targeting IL-1RAP in Patients With High-Risk Myelodysplastic Syndromes (MDS

> **NCT07455500** · NA · NOT_YET_RECRUITING · sponsor: **University Hospital, Grenoble** · enrollment: 120 (estimated)

## Conditions studied

- Myelodysplastic Syndrome

## Interventions

- **OTHER:** Bone marrow and blood sampling

## Key facts

- **NCT ID:** NCT07455500
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2030-01
- **Final completion:** 2031-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07455500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07455500, "Study of an Innovative Therapy Using CAR-T Cells Targeting IL-1RAP in Patients With High-Risk Myelodysplastic Syndromes (MDS". Retrieved via AI Analytics 2026-09-23 from https://api.ai-analytics.org/clinical/NCT07455500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*